These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24584429)

  • 21. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.
    Sweeney MO; Bank AJ; Nsah E; Koullick M; Zeng QC; Hettrick D; Sheldon T; Lamas GA;
    N Engl J Med; 2007 Sep; 357(10):1000-8. PubMed ID: 17804844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contributions of permanent cardiac pacing in the treatment of atrial fibrillation.
    Schuchert A
    Europace; 2004 Sep; 5 Suppl 1():S36-41. PubMed ID: 15450278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a pacing mode preserving spontaneous AV conduction on ventricular pacing burden and atrial arrhythmias.
    Rey JL; Quenum S; Hero M
    Pacing Clin Electrophysiol; 2012 May; 35(5):580-5. PubMed ID: 22339661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pacing for the prevention of atrial fibrillation.
    Gillis AM; Kerr CR; Crystal E
    Can J Cardiol; 2005 Sep; 21 Suppl B():41B-44B. PubMed ID: 16239987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathophysiology of pacing in patients with atrial fibrillation].
    Geller JC; Reek S
    Herzschrittmacherther Elektrophysiol; 2002 Mar; 13(1):11-9. PubMed ID: 24584428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biatrial pacing--new possibility in the non-pharmacologic treatment of drug-resistant paroxysmal atrial fibrillation].
    Merkely B; Vágó H; Gellér L; Zima E; Tomcsányi J; Bodor E
    Orv Hetil; 2001 Feb; 142(5):235-40. PubMed ID: 11243011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.
    Knight BP; Gersh BJ; Carlson MD; Friedman PA; McNamara RL; Strickberger SA; Tse HF; Waldo AL; ; ; ;
    Circulation; 2005 Jan; 111(2):240-3. PubMed ID: 15657388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study.
    Russo V; Rago A; Politano L; Della Cioppa N; Russo MG; Golino P; Calabrò R; Nigro G
    Europace; 2012 Apr; 14(4):486-9. PubMed ID: 22135319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
    de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP
    Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Atrial Pacing Peri-ablation for Paroxysmal Atrial Fibrillation (PA3) Study: rationale and study design.
    Gillis AM
    Europace; 1999 Jan; 1(1):40-2. PubMed ID: 11220538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of pacemaker-detected atrial high-rate episodes.
    Mandava A; Mittal S
    Curr Opin Cardiol; 2008 Jan; 23(1):60-4. PubMed ID: 18281829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pacemaker prevention therapy in drug-refractory paroxysmal atrial fibrillation: reliability of diagnostics and effectiveness of prevention pacing therapy in Vitatron selection device.
    Terranova P; Valli P; Terranova P; Dell'Orto S; Greco EM
    Indian Pacing Electrophysiol J; 2006 Apr; 6(2):63-74. PubMed ID: 16943898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atrial fibrillation: stimulation and pacemaker therapy].
    Lewalter T; Yang A; Bielik H; Schrickel J; Lüderitz B
    Herz; 2002 Jun; 27(4):345-56. PubMed ID: 12187864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dual chamber pacemaker in the treatment of paroxysmal atrial fibrillation].
    Raden G; Rafajlovski S; Perisic Z; Romanovic R
    Vojnosanit Pregl; 2005 Apr; 62(4):329-34. PubMed ID: 15889600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical application of pacemakers in atrial tachyarrhythmias.
    de Voogt WG; van Hemel NM
    Neth Heart J; 2008 Oct; 16(Suppl 1):S20-4. PubMed ID: 18958264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial pacing in the prevention of paroxysmal atrial fibrillation: first results of a new combined algorithm.
    Israel CW; Lawo T; Lemke B; Grönefeld G; Hohnloser SH
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1888-90. PubMed ID: 11139950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of the epidemiology, pathogenesis and prevention of atrial fibrillation after pacemaker implantation.
    Wu Y; Xu H; Tu X; Gao Z
    Adv Clin Exp Med; 2023 Jun; 32(6):707-718. PubMed ID: 36881357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective randomized comparison between fixed rate response programming and automatic rate response optimization in activity-triggered DDDR pacemakers. Thera Pacemaker Study Group.
    Schuchert A; van Langen H; Michels K; Meinertz T
    Cardiology; 1998; 89(1):25-8. PubMed ID: 9452153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.